Clinical Trial Update: Indole-3-PROpionic Acid Clinical Trials - Multiple Sclerosis [NA]

View source ↗

Summary

A clinical trial investigating indole-3-propionic acid for relapsing-remitting multiple sclerosis is currently recruiting in Copenhagen. Sponsor: Glostrup Unive…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Relapsing-remitting Multiple Sclerosis

Drugs mentioned

• Indole-3-propionic acid (Indole-3-propionic acid)

Snippet

Sponsor: Glostrup University Hospital, Copenhagen | Conditions: Relapsing Remitting Multiple Sclerosis (RRMS) | NA | Status: RECRUITING